TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
BioCardia ( (BCDA) ) has shared an update.
On December 2, 2025, BioCardia, Inc. announced the appointment of Marvin Slosman to its Board of Directors, effective immediately, with his term expiring at the 2028 Annual Meeting of Shareholders. Mr. Slosman, who is also the CEO of InspireMD, brings extensive experience in interventional cardiology and global market expansion. His appointment follows the completion of Dr. Richard Krasno’s term, who has been instrumental in guiding the company through significant milestones. The company’s Annual Meeting on the same day saw the election of Class III directors and approval of key proposals, including amendments to the 2016 Equity Incentive Plan and ratification of PKF San Diego, LLP as the independent accounting firm.
The most recent analyst rating on (BCDA) stock is a Hold with a $1.50 price target. To see the full list of analyst forecasts on BioCardia stock, see the BCDA Stock Forecast page.
Spark’s Take on BCDA Stock
According to Spark, TipRanks’ AI Analyst, BCDA is a Neutral.
BioCardia’s overall stock score is primarily impacted by its weak financial performance and concerning valuation metrics. While there are positive developments in clinical trials and regulatory progress, the financial instability and negative valuation indicators weigh heavily on the stock’s attractiveness.
To see Spark’s full report on BCDA stock, click here.
More about BioCardia
BioCardia, Inc., headquartered in Sunnyvale, California, is a global leader in cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases. The company offers biotherapeutic platforms such as CardiAMP autologous and CardiALLO allogeneic cell therapies, supported by its Helix biotherapeutic delivery and Morph vascular navigation product platforms.
Average Trading Volume: 594,714
Technical Sentiment Signal: Sell
Current Market Cap: $14.75M
Learn more about BCDA stock on TipRanks’ Stock Analysis page.